Please login to the form below

Not currently logged in

Pharma deals in April 2015

Medius Deal Watch

The love affair with oncology continues, finds Medius Deal Watch

Medius Deal Watch table for April 2015

Medius Deal WatchThe top major pharma mergers, acquisitions and collaborations during the month continued pharma's love affair with oncology

Pharma deals in March 2015

Medius Deal WatchAbbVie's Pharmacyclics mega-merger dominated the month, finds Medius Deal Watch

Medius Deal Watch table for March 2015

Medius Deal WatchThe top major pharma mergers, acquisitions and collaborations during the month were dominated by AbbVie's Pharmacyclics mega-merger

Rise of generics will curb France’s pharma growth

Generics are set to take a serious bite out of the market as a cash-strapped government pushes for cost controls


Sales reps in the digital age

As the number of doctors willing to see pharmaceutical sales representatives in person declines how digital tools can help with access, reach and rep effectiveness?

Next-generation KOL intelligence

Advances in KOL intelligence are delivering richer insights into clinical landscapes than ever before, better enabling pharma to meet the challenges of an increasingly competitive and complex environment for KOL

Is co-creation the key to customer-centricity?

As pharma grapples with the need to becomemore doctor- and patient-centric, can co-creation help it better engage andconnect with its audience by redefining industry relationships with physicians and improve patient

Holistic market access and the importance of early engagement

Holistic market accessThere are two key elements in any successful strategy: knowing what to do, and knowing when to do it. Yet in terms of market access, there appears to be a

Country reports

Is obesity really a problem in Brazil?

Obesity is on the rise in low- and middle-income countries, particularly in urban settings

Turkey: A growing pharma market with huge potential

The Turkish biopharma market offers many opportunities - if it can overcome its sustainability challenge

Creating a 21st century life sciences ecosystem

UK life sciences minister George FreemanThe UK’s life sciences minister on how government and pharma can encourage NHS uptake and innovation


The challenge of antimicrobial resistance

Cubist Patrick-Vink Cubist's Patrick Vink on the company's ambitions in anti-infectives

Switching to a virtual healthcare system

babylon virtual health service Ali Parsa, CEO and founder of babylon, discusses the benefits of conducting healthcare consultations via a smartphone

The role of artificial intelligence in healthcare

Watson on jeopardy IBM's Amer Fasihi on the rise of Watson

White papers

When forecasters take the floor: 6 tips on presenting a forecast

Peter Mansell queries some of pharma’s leading forecasters for their dos and don’ts on presenting a forecast

Enablers of drug innovation could lie in the numbers

Christopher Ehinger of Black Swan Analysis addresses the problem of clinical-trial recruitment as a barrier to new drug development and offers a new way of looking at the problem.

Forecasting for Licensed Compounds

Peter Mansell examines the impact of heavier in-licensing/out-licensing traffic on pharmaceutical forecasting

When to use patient flow analysis and how to get it right

With the evolution of forecasting models, analysts have more tools at their disposal to accurately forecast drugs and diagnostics.

Featured jobs

Subscribe to our email news alerts


Add my company
McCann Health

The most globally awarded health agency network and currently Health Network agency of The Year. Comprising of two specialist agencies:...